A novel therapeutic technology of specific RNA inhibition for acute promyelocytic leukemia: improved design of maxizymes against PML/RARalpha mRNA.

Hirotsugu Suwanai, Hiromichi Matsushita, Hiroyuki Kobayashi, Yasuo Ikeda, Masahiro Kizaki

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A novel therapeutic technology of specific RNA inhibition for acute promyelocytic leukemia: improved design of maxizymes against PML/RARalpha mRNA.'. Together they form a unique fingerprint.

Medicine & Life Sciences